Good day everyone. And welcome to the ICL Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. Later you will have the opportunity to ask questions ...

In alignment with the Company’s efficiency plan, which includes a change of reporting responsibilities as of January 2024, the results of a non-phosphate related business were allocated from the ...

Less than two years after Brazil was rocked by a coup attempt, a one-man terrorist attack is reigniting the conversation ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

November 13, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and ...

We are tackling every major issue facing the world today, from fighting malaria and infections, to antimicrobial resistance, climate change and the ecology of our planet. Explore the breadth of our ...

Our research themes are highly interdisciplinary and involve collaborations with departments from all faculties in the College, London hospitals, and international universities and research centres.